Literature DB >> 8559657

Stereodifferentiation--the effect of P chirality of oligo(nucleoside phosphorothioates) on the activity of bacterial RNase H.

M Koziolkiewicz1, A Krakowiak, M Kwinkowski, M Boczkowska, W J Stec.   

Abstract

P stereoregular phosphorothioate analogs of pentadecamer 5'-d(AGATGTTTGAGCTCT)-3' were synthesized by the oxathiaphospholane method. Their diastereomeric purity was assigned by means of enzymatic degradation with nuclease P1 and, independently, with snake venom phosphodiesterase. DNA-RNA hybrids formed by phosphorothioate oligonucleotides (PS-oligos) with the corresponding complementary pentadecaribonucleotide were treated with bacterial RNase H. The DNA-RNA complex containing the PS-oligo of [all-RP] configuration was found to be more susceptible to RNase H-dependent degradation of the pentadecaribonucleotide compared with hybrids containing either the [all-SP] counterpart or the so called 'random mixture of diastereomers' of the pentadeca(nucleoside phosphorothioate). This stereodependence of RNase H action was also observed for a polyribonucleotide (475 nt) hybridized with these phosphorothioate oligonucleotides. The results of melting studies of PS-oligo-RNA hybrids allowed a rationalization of the observed stereodifferentiation in terms of the higher stability of heterodimers formed between oligoribonucleotides and [all-RP]-oligo(nucleoside phosphorothioates), compared with the less stable heterodimers formed with [all-SP]-oligo(nucleoside phosphorothioates) or the random mixture of diastereomers.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8559657      PMCID: PMC307505          DOI: 10.1093/nar/23.24.5000

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  21 in total

Review 1.  Nucleoside phosphorothioates.

Authors:  F Eckstein
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

2.  RNase H cleavage of RNA hybridized to oligonucleotides containing methylphosphonate, phosphorothioate and phosphodiester bonds.

Authors:  P J Furdon; Z Dominski; R Kole
Journal:  Nucleic Acids Res       Date:  1989-11-25       Impact factor: 16.971

Review 3.  Oligonucleotide analogues as potential chemotherapeutic agents.

Authors:  G Zon
Journal:  Pharm Res       Date:  1988-09       Impact factor: 4.200

4.  Role of RNase H in hybrid-arrested translation by antisense oligonucleotides.

Authors:  R Y Walder; J A Walder
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

5.  Separation and characterization of diastereoisomers of antisense oligodeoxyribonucleoside phosphorothioates.

Authors:  A Murakami; Y Tamura; H Wada; K Makino
Journal:  Anal Biochem       Date:  1994-12       Impact factor: 3.365

6.  Bond order and charge localization in nucleoside phosphorothioates.

Authors:  P A Frey; R D Sammons
Journal:  Science       Date:  1985-05-03       Impact factor: 47.728

7.  Stereochemistry of hydrolysis by snake venom phosphodiesterase.

Authors:  P M Burgers; F Eckstein; D H Hunneman
Journal:  J Biol Chem       Date:  1979-08-25       Impact factor: 5.157

8.  A bacteriophage T7 RNA polymerase/promoter system for controlled exclusive expression of specific genes.

Authors:  S Tabor; C C Richardson
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

9.  Inhibition of cAMP-dependent protein kinase by adenosine cyclic 3'-, 5'-phosphorodithioate, a second cAMP antagonist.

Authors:  L H Botelho; L C Webster; J D Rothermel; J Baraniak; W J Stec
Journal:  J Biol Chem       Date:  1988-04-15       Impact factor: 5.157

10.  Synthesis and configurational analysis of a dinucleoside phosphate isotopically chiral at phosphorus. Stereochemical course of Penicillium citrum nuclease P1 reaction.

Authors:  B V Potter; B A Connolly; F Eckstein
Journal:  Biochemistry       Date:  1983-03-15       Impact factor: 3.162

View more
  16 in total

1.  Synthesis, biophysical properties and biological activity of second generation antisense oligonucleotides containing chiral phosphorothioate linkages.

Authors:  W Brad Wan; Michael T Migawa; Guillermo Vasquez; Heather M Murray; Josh G Nichols; Hans Gaus; Andres Berdeja; Sam Lee; Christopher E Hart; Walt F Lima; Eric E Swayze; Punit P Seth
Journal:  Nucleic Acids Res       Date:  2014-11-14       Impact factor: 16.971

Review 2.  The chemical evolution of oligonucleotide therapies of clinical utility.

Authors:  Anastasia Khvorova; Jonathan K Watts
Journal:  Nat Biotechnol       Date:  2017-02-27       Impact factor: 54.908

3.  Structural basis of the RNase H1 activity on stereo regular borano phosphonate DNA/RNA hybrids.

Authors:  Christopher N Johnson; Alexander M Spring; Dimitri Sergueev; Barbara R Shaw; Markus W Germann
Journal:  Biochemistry       Date:  2011-04-19       Impact factor: 3.162

4.  Control of phosphorothioate stereochemistry substantially increases the efficacy of antisense oligonucleotides.

Authors:  Naoki Iwamoto; David C D Butler; Nenad Svrzikapa; Susovan Mohapatra; Ivan Zlatev; Dinah W Y Sah; Stephany M Standley; Genliang Lu; Luciano H Apponi; Maria Frank-Kamenetsky; Jason Jingxin Zhang; Chandra Vargeese; Gregory L Verdine
Journal:  Nat Biotechnol       Date:  2017-08-21       Impact factor: 54.908

Review 5.  Antisense technology: A review.

Authors:  Stanley T Crooke; Xue-Hai Liang; Brenda F Baker; Rosanne M Crooke
Journal:  J Biol Chem       Date:  2021-02-16       Impact factor: 5.157

Review 6.  DNA and RNA derivatives to optimize distribution and delivery.

Authors:  Eric Wickstrom
Journal:  Adv Drug Deliv Rev       Date:  2015-04-22       Impact factor: 15.470

7.  Stereochemical bias introduced during RNA synthesis modulates the activity of phosphorothioate siRNAs.

Authors:  Hartmut Jahns; Martina Roos; Jochen Imig; Fabienne Baumann; Yuluan Wang; Ryan Gilmour; Jonathan Hall
Journal:  Nat Commun       Date:  2015-03-06       Impact factor: 14.919

8.  Electronic Structures of LNA Phosphorothioate Oligonucleotides.

Authors:  Henrik G Bohr; Irene Shim; Cy Stein; Henrik Ørum; Henrik F Hansen; Troels Koch
Journal:  Mol Ther Nucleic Acids       Date:  2017-06-01       Impact factor: 8.886

9.  Understanding the effect of controlling phosphorothioate chirality in the DNA gap on the potency and safety of gapmer antisense oligonucleotides.

Authors:  Michael E Østergaard; Cheryl L De Hoyos; W Brad Wan; Wen Shen; Audrey Low; Andres Berdeja; Guillermo Vasquez; Susan Murray; Michael T Migawa; Xue-Hai Liang; Eric E Swayze; Stanley T Crooke; Punit P Seth
Journal:  Nucleic Acids Res       Date:  2020-02-28       Impact factor: 16.971

Review 10.  Targeting RNA: A Transformative Therapeutic Strategy.

Authors:  Wei Yin; Mark Rogge
Journal:  Clin Transl Sci       Date:  2019-02-27       Impact factor: 4.689

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.